
Ziaul Karim
Examiner (ID: 14835, Phone: (571)270-3279 , Office: P/2127 )
| Most Active Art Unit | 2119 |
| Art Unit(s) | 2127, 2119 |
| Total Applications | 971 |
| Issued Applications | 802 |
| Pending Applications | 63 |
| Abandoned Applications | 133 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18955149
[patent_doc_number] => 20240043476
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-08
[patent_title] => ANTI-TUMOR PEPTIDE AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/761255
[patent_app_country] => US
[patent_app_date] => 2021-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6561
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17761255
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/761255 | ANTI-TUMOR PEPTIDE AND USE THEREOF | Aug 17, 2021 | Abandoned |
Array
(
[id] => 17428366
[patent_doc_number] => 20220056074
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-24
[patent_title] => PEPTIDE COMPOUND WITH REPETITIVE SEQUENCES
[patent_app_type] => utility
[patent_app_number] => 17/401434
[patent_app_country] => US
[patent_app_date] => 2021-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15717
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -58
[patent_words_short_claim] => 160
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17401434
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/401434 | PEPTIDE COMPOUND WITH REPETITIVE SEQUENCES | Aug 12, 2021 | Pending |
Array
(
[id] => 17760020
[patent_doc_number] => 20220233632
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-28
[patent_title] => MODULATORS OF COMPLEMENT ACTIVITY
[patent_app_type] => utility
[patent_app_number] => 17/400267
[patent_app_country] => US
[patent_app_date] => 2021-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34995
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17400267
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/400267 | Modulators of complement activity | Aug 11, 2021 | Issued |
Array
(
[id] => 19097757
[patent_doc_number] => 20240116985
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-11
[patent_title] => STAPLED PEPTIDES AND METHODS THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/017024
[patent_app_country] => US
[patent_app_date] => 2021-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 149578
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -44
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18017024
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/017024 | STAPLED PEPTIDES AND METHODS THEREOF | Jul 21, 2021 | Pending |
Array
(
[id] => 17214492
[patent_doc_number] => 20210347829
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-11
[patent_title] => ARC-BASED CAPSIDS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/382092
[patent_app_country] => US
[patent_app_date] => 2021-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32028
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17382092
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/382092 | Endogenous Gag-based capsids and uses thereof | Jul 20, 2021 | Issued |
Array
(
[id] => 18629526
[patent_doc_number] => 20230288408
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-14
[patent_title] => NOVEL PEPTIDE TAG
[patent_app_type] => utility
[patent_app_number] => 18/015906
[patent_app_country] => US
[patent_app_date] => 2021-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14117
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18015906
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/015906 | NOVEL PEPTIDE TAG | Jul 14, 2021 | Pending |
Array
(
[id] => 19594224
[patent_doc_number] => 12152054
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-11-26
[patent_title] => Methods of purifying polypeptides
[patent_app_type] => utility
[patent_app_number] => 17/369765
[patent_app_country] => US
[patent_app_date] => 2021-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 74
[patent_no_of_words] => 31190
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 132
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17369765
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/369765 | Methods of purifying polypeptides | Jul 6, 2021 | Issued |
Array
(
[id] => 18510048
[patent_doc_number] => 20230226146
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-20
[patent_title] => ACTRII PROTEINS FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION (PAH)
[patent_app_type] => utility
[patent_app_number] => 18/011261
[patent_app_country] => US
[patent_app_date] => 2021-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 65308
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -207
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18011261
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/011261 | ACTRII PROTEINS FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION (PAH) | Jun 21, 2021 | Pending |
Array
(
[id] => 18177909
[patent_doc_number] => 20230038638
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-09
[patent_title] => COMPLEMENT FACTOR I-RELATED COMPOSITIONS AND METHODS
[patent_app_type] => utility
[patent_app_number] => 17/347442
[patent_app_country] => US
[patent_app_date] => 2021-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 55653
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17347442
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/347442 | Complement factor I-related compositions and methods | Jun 13, 2021 | Issued |
Array
(
[id] => 18692558
[patent_doc_number] => 20230322856
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-12
[patent_title] => COMPOSITION COMPRISING REGENTIDE-012 OR REGENTIDE-013 FOR IMPROVING SKIN CONDITION
[patent_app_type] => utility
[patent_app_number] => 17/997808
[patent_app_country] => US
[patent_app_date] => 2021-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7224
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17997808
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/997808 | COMPOSITION COMPRISING REGENTIDE-012 OR REGENTIDE-013 FOR IMPROVING SKIN CONDITION | Jun 7, 2021 | Pending |
Array
(
[id] => 18391372
[patent_doc_number] => 20230159590
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-25
[patent_title] => REGENTIDE-041 AND COMPOSITION COMPRISING REGENTIDE-041 FOR IMPROVING SKIN CONDITION
[patent_app_type] => utility
[patent_app_number] => 17/997801
[patent_app_country] => US
[patent_app_date] => 2021-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6851
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17997801
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/997801 | REGENTIDE-041 AND COMPOSITION COMPRISING REGENTIDE-041 FOR IMPROVING SKIN CONDITION | Jun 7, 2021 | Pending |
Array
(
[id] => 18496156
[patent_doc_number] => 20230218707
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-13
[patent_title] => NOVEL PEPTIDE INHIBITORS OF BETA-LACTAMASE AGAINST ANTIBIOTIC RESISTANCE
[patent_app_type] => utility
[patent_app_number] => 17/999974
[patent_app_country] => US
[patent_app_date] => 2021-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7819
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17999974
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/999974 | NOVEL PEPTIDE INHIBITORS OF BETA-LACTAMASE AGAINST ANTIBIOTIC RESISTANCE | Jun 3, 2021 | Pending |
Array
(
[id] => 18530231
[patent_doc_number] => 20230235301
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-27
[patent_title] => Compounds and Methods for Treating, Ameliorating, or Preventing Herpes Ocular Keratitis
[patent_app_type] => utility
[patent_app_number] => 18/000644
[patent_app_country] => US
[patent_app_date] => 2021-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18389
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18000644
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/000644 | Compounds and Methods for Treating, Ameliorating, or Preventing Herpes Ocular Keratitis | Jun 2, 2021 | Pending |
Array
(
[id] => 17110193
[patent_doc_number] => 20210290790
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-23
[patent_title] => METHOD FOR PRODUCING PROTEIN COMPOSITION, AND PROTEIN COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 17/336672
[patent_app_country] => US
[patent_app_date] => 2021-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11859
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17336672
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/336672 | Method for producing protein composition, and protein composition | Jun 1, 2021 | Issued |
Array
(
[id] => 17776566
[patent_doc_number] => 20220242915
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-04
[patent_title] => SODIUM CHANNEL PROTEIN NAV1.4-TARGETING POLYPEPTIDE AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/329194
[patent_app_country] => US
[patent_app_date] => 2021-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3075
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17329194
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/329194 | Sodium channel protein Nav1.4-targeting polypeptide and use thereof | May 24, 2021 | Issued |
Array
(
[id] => 19550967
[patent_doc_number] => 12134664
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-11-05
[patent_title] => Muramyl peptide derivatives
[patent_app_type] => utility
[patent_app_number] => 17/328078
[patent_app_country] => US
[patent_app_date] => 2021-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 11
[patent_no_of_words] => 13187
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17328078
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/328078 | Muramyl peptide derivatives | May 23, 2021 | Issued |
Array
(
[id] => 17082051
[patent_doc_number] => 20210277057
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-09
[patent_title] => ADVANTAGEOUS MU-OPIATE RECEPTOR PEPTIDE COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 17/328045
[patent_app_country] => US
[patent_app_date] => 2021-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1772
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17328045
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/328045 | ADVANTAGEOUS MU-OPIATE RECEPTOR PEPTIDE COMPOUNDS | May 23, 2021 | Abandoned |
Array
(
[id] => 17185231
[patent_doc_number] => 20210332116
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-28
[patent_title] => SINGLE DOMAIN BINDING MOLECULE
[patent_app_type] => utility
[patent_app_number] => 17/322139
[patent_app_country] => US
[patent_app_date] => 2021-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11744
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17322139
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/322139 | Single domain binding molecule | May 16, 2021 | Issued |
Array
(
[id] => 17228912
[patent_doc_number] => 20210355468
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-18
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING LEWY BODY DEMENTIA
[patent_app_type] => utility
[patent_app_number] => 17/320386
[patent_app_country] => US
[patent_app_date] => 2021-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26686
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17320386
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/320386 | COMPOSITIONS AND METHODS FOR TREATING LEWY BODY DEMENTIA | May 13, 2021 | Abandoned |
Array
(
[id] => 17299479
[patent_doc_number] => 20210395318
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-23
[patent_title] => MULTISPECIFIC PROTEINS
[patent_app_type] => utility
[patent_app_number] => 17/302898
[patent_app_country] => US
[patent_app_date] => 2021-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44923
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17302898
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/302898 | Multispecific proteins | May 13, 2021 | Issued |